Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole.

NCT04872920 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-08-30

No results posted yet for this study

Summary

This is a non-interventional, prospective, multinational, multicentre, observational study, in which data collected are those derived from routine clinical practice via an European registry on CS: ERCUSYN.

Conditions

  • Cushing Syndrome

Sponsors & Collaborators

  • HRA Pharma

    lead INDUSTRY

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-20
Primary Completion
2023-03-01
Completion
2024-03-01

Countries

  • Croatia
  • France
  • Spain
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04872920 on ClinicalTrials.gov